T2 Biosystems to Attend Upcoming Investor Conferences
01 août 2024 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Second Quarter 2024 Financial Results
29 juil. 2024 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor
29 juil. 2024 16h02 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the...
T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
22 juil. 2024 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
25 juin 2024 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the...
T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
22 mai 2024 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
17 mai 2024 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
15 mai 2024 07h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock
14 mai 2024 17h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
07 mai 2024 09h00 HE
|
T2 Biosystems, Inc.
Filed Pursuant to Rule 433Issuer Free Writing Prospectus dated May 6, 2024Relating to Preliminary Prospectus dated May 6, 2024Registration No. 333-278866 LEXINGTON, Mass., May 07, 2024 (GLOBE...